FDA chief vows mifepristone probe

Sports News


96
sup, sub { font-size: 100% !necessary; } sup { mso-text-raise:10% } sub { mso-text-raise:-10% }

Offered by Alliance for Pharmacy Compounding — The Meals and Drug Administration commissioner has dedicated to reviewing the abortion drug mifepristone after beforehand stating he had no plans to “take motion” on the drug.  
{beacon}